Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Brunner HI
  • Tzaribachev N
  • Cornejo GV
  • Joos R
  • Gervais E
  • Cimaz R
  • Cuttica R
  • Lutz T
  • Quartier P
  • Gandhi Y
  • Nys M
  • Wong R
  • Martini A
  • Lovell DJ
  • Ruperto N
  • Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology

Grupos

Abstract

Patients with polyarticular-course juvenile idiopathic arthritis (pJIA), receiving disease-modifying anti-rheumatic drugs with immunosuppressive effects, may be at increased risk of vaccine-preventable infections. This substudy assessed protective antibody responses to diphtheria and tetanus vaccination given prior to study enrolment in patients with pJIA.

Datos de la publicación

ISSN/ISSNe:
1546-0096, 1546-0096

Pediatric Rheumatology  BMC

Tipo:
Article
Páginas:
19-19
PubMed:
32087715
Factor de Impacto:
1,051 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 11

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Abatacept, Biologic DMARDs, Juvenile idiopathic arthritis, Vaccination

Cita

Compartir